Literature DB >> 29375221

The Association between Monocyte HDL-C Ratio and SYNTAX Score and SYNTAX Score II in STEMI Patients Treated with Primary PCI.

Metin Çağdaş1, Süleyman Karakoyun1, Mahmut Yesin2, İbrahim Rencüzoğulları1, Yavuz Karabağ1, Mahmut Uluganyan3, Mustafa Ozan Gürsoy4, İnanç Artaç1, Doğan İliş1, Eray Atalay5, Öznur Sadioğlu Çağdaş6.   

Abstract

BACKGROUND: Monocyte to high-density-lipoprotein cholesterol ratio (MHR) simply reflects proatherogenic and antiatherogenic balance and high level of this ratio is associated with severity of coronary atherosclerosis and cardiac events. We investigated the association between MHR and coronary artery disease severity using SYNTAX score and SYNTAX score II (SSII) in ST-elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (pPCI).
METHODS: A total of 315 consecutive patients with STEMI who underwent pPCI from January 2014 to January 2016 were enrolled. After exclusion 264 patients remained in the study population. Patients were divided into 2 groups according to median SSII [SSII ≤ 34.2 as low group (n = 132) and > 34.2 as high group (n = 132)].
RESULTS: Median value of MHR was 10.5 in SSII low group and 16.1 in SSII high group (p < 0.001). There was a strong correlation between MHR and SSII (r = 0.580, p < 0.001). Diabetes mellitus [odds ratio (OR): 8.604; 95% confidence interval (CI): 2.469-29.978], glomerular filtration rate (OR: 0.961; 95% CI: 0.939-0.983), infarct related artery of left anterior descending (LAD) (OR: 7.325; 95% CI: 2.262-23.723), SYNTAX score (OR: 1.422; 95% CI: 1.275-1.585), neutrophil to lymphocyte ratio (NLR) (OR: 1.156; 95% CI: 1.058-1.264) and MHR (OR: 1.027; 95% CI: 1.013-1.041) were independent predictors of SSII > 34.2 in multivariate analysis.
CONCLUSIONS: MHR could be a better parameter than NLR and C-reactive protein at predicting severity of coronary artery disease in STEMI patients treated with pPCI.

Entities:  

Keywords:  Monocyte to high density cholesterol ratio; ST elevation myocardial infarction; SYNTAX score; SYNTAX score II

Year:  2018        PMID: 29375221      PMCID: PMC5777940          DOI: 10.6515/ACS.201801_34(1).20170823A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  30 in total

Review 1.  Monocytes as a diagnostic marker of cardiovascular diseases.

Authors:  Alexei Gratchev; Igor Sobenin; Alexander Orekhov; Julia Kzhyshkowska
Journal:  Immunobiology       Date:  2012-01-13       Impact factor: 3.144

2.  Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease.

Authors:  Hiroaki Taniguchi; Yukihiko Momiyama; Reiko Ohmori; Atsushi Yonemura; Takeshi Yamashita; Seiichi Tamai; Haruo Nakamura; Fumitaka Ohsuzu
Journal:  Atherosclerosis       Date:  2005-01       Impact factor: 5.162

Review 3.  Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction.

Authors:  Rolf Schröder
Journal:  Circulation       Date:  2004-11-23       Impact factor: 29.690

4.  Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease.

Authors:  H Kundi; E Kiziltunc; M Cetin; H Cicekcioglu; Z G Cetin; G Cicek; E Ornek
Journal:  Herz       Date:  2016-01-11       Impact factor: 1.443

5.  Age as a modulator of inflammatory cardiovascular risk factors.

Authors:  Erdembileg Anuurad; Byambaa Enkhmaa; Zeynep Gungor; Wei Zhang; Russell P Tracy; Thomas A Pearson; Kyoungmi Kim; Lars Berglund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-23       Impact factor: 8.311

6.  Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.

Authors:  Mehmet Kanbay; Yalcin Solak; Hilmi Umut Unal; Yasemin Gulcan Kurt; Mahmut Gok; Hakki Cetinkaya; Murat Karaman; Yusuf Oguz; Tayfun Eyileten; Abdulgaffar Vural; Adrian Covic; David Goldsmith; Osman Turak; Mahmut Ilker Yilmaz
Journal:  Int Urol Nephrol       Date:  2014-05-23       Impact factor: 2.370

7.  Association of Neutrophil-to-Lymphocyte Ratio with the Severity and Morphology of Coronary Atherosclerotic Plaques Detected by Multidetector Computerized Tomography.

Authors:  Ahmet Hakan Ateş; Kudret Aytemir; Duygu Koçyiğit; Muhammed Ulvi Yalcin; Kadri Murat Gürses; Hikmet Yorgun; Uğur Canpolat; Tuncay Hazırolan; Necla Özer
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

Review 8.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

9.  Plasma High-Sensitivity C-Reactive Protein Level is Associated with Impaired Estimated Glomerular Filtration Rate in Hypertensives.

Authors:  Hsu-Shien Shu; Yi-Yun Tai; Kai-Ting Chang; Chun-Yuan Chu; Po-Chao Hsu; Ho-Ming Su; Tsung-Hsien Lin; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

10.  Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry.

Authors:  Carlos M Campos; David van Klaveren; Javaid Iqbal; Yoshinobu Onuma; Yao-Jun Zhang; Hector M Garcia-Garcia; Marie-Angele Morel; Vasim Farooq; Hiroki Shiomi; Yutaka Furukawa; Yoshihisa Nakagawa; Kazushige Kadota; Pedro A Lemos; Takeshi Kimura; Ewout W Steyerberg; Patrick W Serruys
Journal:  Circ J       Date:  2014-07-07       Impact factor: 2.993

View more
  6 in total

1.  The Relationship between Nesfatin-1 Levels and SYNTAX Score in Patients with Non-ST Segment Elevation Myocardial Infarction.

Authors:  Mevlüt Serdar Kuyumcu; Aliye Kuyumcu; Çağrı Yayla; Mustafa Bilal Özbay; Sefa Ünal; Burak Açar; Cemil Nural; Almila Şenat; Gülhan Samur
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

2.  Monocyte-to-HDL-cholesterol ratio is associated with Ascending Aorta Dilatation in Patients with Bicuspid Aortic Valve.

Authors:  Burak Acar; Cagrı Yayla; Murat Gul; Mustafa Karanfil; Sefa Unal; Fatih Uçar; Serdar Mevlut Kuyumcu; Ahmet Goktug Ertem; Yasin Ozen; Mustafa Bilal Ozbay; Ozcan Ozeke; Sinan Aydogdu
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

3.  Association of Serum Copeptin Levels with Patency of Infarct-Related Arteries in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Birsen Doganay; Sercan Okutucu; Mustafa Cetin; Emrullah Kızıltunc; Orhan Karayigit; Can Ozkan; Muhammed Fevzi Kılınckaya; Ender Ornek
Journal:  Acta Cardiol Sin       Date:  2019-07       Impact factor: 2.672

4.  Clinical, Demographic, and Biochemical Characteristics of Patients with Acute ST-Segment Elevation Myocardial Infarction: An Analysis of Acute Coronary Syndrome Registry Data of a Single Medical Center from 2005 to 2016.

Authors:  Chun-Chung Lin; Pei-Yu Lee; Kuo-Chin Chen; Pen-Chih Liao; Jung-Cheng Hsu; Ai-Hsien Li
Journal:  Acta Cardiol Sin       Date:  2020-01       Impact factor: 2.672

5.  Hyperhomocysteinemia Predicts the Severity of Coronary Artery Disease as Determined by the SYNTAX Score in Patients with Acute Coronary Syndrome.

Authors:  Muhammed Karadeniz; Taner Sarak; Mustafa Duran; Caglar Alp; Huseyin Kandemir; İbrahim Etem Celik; Vedat Simsek; Alparslan Kılıc
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

6.  ALT-to-Lymphocyte Ratio as a Predictor of Long-Term Mortality in Patients with Normal Liver Function Presenting Coronary Artery Disease after Undergoing PCI: A Retrospective Cohort Study.

Authors:  Ru-Jie Zheng; Qian-Qian Guo; Jun-Nan Tang; Xu-Ming Yang; Jian-Chao Zhang; Meng-Die Cheng; Feng-Hua Song; Zhi-Yu Liu; Kai Wang; Li-Zhu Jiang; Lei Fan; Xiao-Ting Yue; Yan Bai; Xin-Ya Dai; Zeng-Lei Zhang; Ying-Ying Zheng; Jin-Ying Zhang
Journal:  J Interv Cardiol       Date:  2020-04-21       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.